Annual SG&A
$8.13 M
-$4.73 M-36.76%
31 December 2023
Summary:
Cyclerion Therapeutics annual selling, general & administrative expenses is currently $8.13 million, with the most recent change of -$4.73 million (-36.76%) on 31 December 2023. During the last 3 years, it has fallen by -$20.68 million (-71.78%). CYCN annual SG&A is now -76.36% below its all-time high of $34.40 million, reached on 31 December 2019.CYCN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.24 M
-$38.00 K-2.97%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly selling, general & administrative expenses is currently $1.24 million, with the most recent change of -$38.00 thousand (-2.97%) on 30 September 2024. Over the past year, it has dropped by -$890.00 thousand (-41.76%). CYCN quarterly SG&A is now -88.69% below its all-time high of $10.98 million, reached on 31 March 2019.CYCN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.07 B
-$5.30 M-0.50%
30 September 2024
Summary:
Cyclerion Therapeutics TTM selling, general & administrative expenses is currently -$1.07 billion, with the most recent change of -$5.30 million (-0.50%) on 30 September 2024. Over the past year, it has dropped by -$1.08 billion (-11156.10%).CYCN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.8% | -41.8% | -10000.0% |
| 3 y3 years | -71.8% | -73.0% | -4640.3% |
| 5 y5 years | -70.5% | -82.6% | -3104.6% |
CYCN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -71.8% | at low | -73.0% | at low | -44.5% | at low |
| 5 y | 5 years | -76.4% | at low | -84.5% | at low | -1060.6% | at low |
| alltime | all time | -76.4% | at low | -88.7% | at low | -3049.0% | at low |
Cyclerion Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.24 M(-3.0%) | $5.87 M(-13.2%) |
| June 2024 | - | $1.28 M(-18.7%) | $6.75 M(-3.5%) |
| Mar 2024 | - | $1.57 M(-11.1%) | $7.00 M(-13.9%) |
| Dec 2023 | $8.13 M(-36.8%) | $1.77 M(-16.9%) | $8.13 M(-15.6%) |
| Sept 2023 | - | $2.13 M(+39.6%) | $9.64 M(-9.2%) |
| June 2023 | - | $1.53 M(-43.5%) | $10.61 M(-15.8%) |
| Mar 2023 | - | $2.70 M(-17.6%) | $12.61 M(-9.0%) |
| Dec 2022 | $12.86 M(-37.6%) | $3.28 M(+5.6%) | $13.86 M(-7.6%) |
| Sept 2022 | - | $3.10 M(-11.8%) | $14.99 M(-9.1%) |
| June 2022 | - | $3.52 M(-10.9%) | $16.49 M(-14.2%) |
| Mar 2022 | - | $3.95 M(-10.4%) | $19.21 M(-6.9%) |
| Dec 2021 | $20.62 M | $4.41 M(-4.1%) | $20.62 M(-12.2%) |
| Sept 2021 | - | $4.60 M(-26.3%) | $23.47 M(-12.8%) |
| June 2021 | - | $6.24 M(+16.3%) | $26.90 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $5.37 M(-26.2%) | $27.29 M(-5.3%) |
| Dec 2020 | $28.82 M(-16.2%) | $7.26 M(-9.6%) | $28.82 M(-0.4%) |
| Sept 2020 | - | $8.03 M(+21.2%) | $28.94 M(+3.3%) |
| June 2020 | - | $6.63 M(-3.8%) | $28.02 M(-7.6%) |
| Mar 2020 | - | $6.89 M(-6.7%) | $30.32 M(-11.9%) |
| Dec 2019 | $34.40 M(+24.9%) | $7.38 M(+3.7%) | $34.40 M(-3.0%) |
| Sept 2019 | - | $7.12 M(-20.2%) | $35.47 M(-1.8%) |
| June 2019 | - | $8.92 M(-18.7%) | $36.14 M(+4.0%) |
| Mar 2019 | - | $10.98 M(+29.9%) | $34.74 M(+26.2%) |
| Dec 2018 | $27.54 M(+82.1%) | $8.45 M(+8.5%) | $27.54 M(+44.3%) |
| Sept 2018 | - | $7.79 M(+3.4%) | $19.09 M(+68.9%) |
| June 2018 | - | $7.53 M(+99.8%) | $11.30 M(+199.8%) |
| Mar 2018 | - | $3.77 M | $3.77 M |
| Dec 2017 | $15.12 M | - | - |
FAQ
- What is Cyclerion Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual SG&A year-on-year change?
- What is Cyclerion Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly SG&A year-on-year change?
- What is Cyclerion Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics TTM SG&A year-on-year change?
What is Cyclerion Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of CYCN is $8.13 M
What is the all time high annual SG&A for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual selling, general & administrative expenses is $34.40 M
What is Cyclerion Therapeutics annual SG&A year-on-year change?
Over the past year, CYCN annual selling, general & administrative expenses has changed by -$4.73 M (-36.76%)
What is Cyclerion Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of CYCN is $1.24 M
What is the all time high quarterly SG&A for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly selling, general & administrative expenses is $10.98 M
What is Cyclerion Therapeutics quarterly SG&A year-on-year change?
Over the past year, CYCN quarterly selling, general & administrative expenses has changed by -$890.00 K (-41.76%)
What is Cyclerion Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of CYCN is -$1.07 B
What is the all time high TTM SG&A for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high TTM selling, general & administrative expenses is $36.14 M
What is Cyclerion Therapeutics TTM SG&A year-on-year change?
Over the past year, CYCN TTM selling, general & administrative expenses has changed by -$1.08 B (-11156.10%)